Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

Clinical trial NCT03353857 · COMPLETED

Trial details

NCT number: NCT03353857
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Biological Availability

Start date: 2017-11-29
Primary completion: 2018-07-04
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.